Unable to load your delegates due to an error Many patients with schizophrenia respond adequately to traditional or atypical antipsychotics, but approximately one-third do not.
This site needs JavaScript to work properly. Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study.
Eur J Prev Cardiol.
Inclusion criteria were randomized, double-blind clinical trials comparing melatonin or melatonin agonists with placebo for the amelioration of AAP-induced effects at any age with selected components of metabolic syndrome as outcome measures. We performed a literature search of PubMed, MEDLINE, EMBASE, PsycINFO, and Cochrane collaboration databases through August 31, …
2016 Feb;23(3):291-307. doi: 10.1177/2047487314562741. 2020 Mar 1;11(2):447-460. doi: 10.1093/advances/nmz070.Kishi T, Nomura I, Sakuma K, Kitajima T, Mishima K, Iwata N.Neuropsychiatr Dis Treat. 2019 Jul 3;9:2045125319859973. doi: 10.1177/2045125319859973.
Outcome: mean change in body mass index from baseline to endpoint. 2008 Jan;105(1-3):101-8. doi: 10.1016/j.jad.2007.04.020.
2019 Jun 15;11(3):64-75. eCollection 2019.Ther Adv Psychopharmacol. Korean College of Neuropsychopharmacology The purpose of this systematic review is to evaluate the data on the use of antipsychotics, antidepressants, anticonvulsants, melatonin, and benzodiazepines for the treatment of behavioral and psychological symptoms of dementia (BPSD) from meta-analyses. SD, standard deviation; IV, inverse variance method; CI, confidence interval; df, degree of freedom. and melatonin secretion in postmenopausal women.
Of 53 records, five RCTs were eligible for the systematic review and three for the meta-analysis.
Atypon Two reviewers independently selected articles and assessed quality using Cochrane risk of bias and concealment tools. Atypical antipsychotics (AAPs) are increasingly used for the treatment of psychotic disorders but are known to be associated with metabolic abnormalities. 2019 Oct 21;9(10):285. doi: 10.3390/brainsci9100285.Neuropsychopharmacology.
This site needs JavaScript to work properly. Outcome: mean change in body weight (kg) from baseline to endpoint. eCollection 2019.
COVID-19 is an emerging, rapidly evolving situation. 2019 Mar;33(3):202-209. doi: 10.1038/s41371-019-0166-2.
Second-generation antipsychotics (SGAs) have been a remarkably effective innovation in psychotropic therapy. 2010 May;24(5):443-52. doi: 10.2165/11204430-000000000-00000.Lee HB, Yoon BH, Kwon YJ, Woo YS, Lee JG, Kim MD, Bahk WM.Clin Drug Investig. Korean College of Neuropsychopharmacology
This study is a systematic review and meta-analysis of randomized controlled trials (RCTs) studying the effectiveness of melatonin for the amelioration of AAP-induced metabolic syndrome. … Melatonin was first isolated from the bovine pineal gland in 1958.
doi: 10.1002/14651858.CD013006.pub2.Mohammadi MR, Mostafavi SA, Hooshyari Z, Khaleghi A, Ahmadi N.Mohammadi MR, Akhondzadeh S, Keshavarz SA, Mostafavi SA.J Nutr Health Aging. The meta-analyses showed no statistically significant difference in any anthropometric or metabolic variable considered. Please enable it to take advantage of the complete set of features!
Name must be less than 100 characters 2013 Oct;33(10):743-53. doi: 10.1007/s40261-013-0120-y.Tully A, Smyth S, Conway Y, Geddes J, Devane D, Kelly JP, Jordan F.Cochrane Database Syst Rev.
2
Electronic databases, i.e.
Atypical antipsychotics (AAPs) are increasingly used for the treatment of psychotic disorders but are known to be associated with metabolic abnormalities.
2020 Jan;45(1):166-175. doi: 10.1038/s41386-019-0474-9. J Clin Endocrinol Metab.
Melatonin (any dosage) vs. placebo in adolescents or adults with bipolar disorder or schizophrenia receiving olanzapine or other atypical antipsychotic with high risk of metabolic disturbances.
eCollection 2019.
Epub 2014 Mar 17.Akbari M, Ostadmohammadi V, Mirhosseini N, Lankarani KB, Tabrizi R, Keshtkaran Z, Reiter RJ, Asemi Z.J Hum Hypertens.
2018 Feb 21;2018:4907264. doi: 10.1155/2018/4907264. Epub 2007 May 24.McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH.Can J Clin Pharmacol.
Clipboard, Search History, and several other advanced features are temporarily unavailable.
2020 Jul 20;7(7):CD013006. 2019 May 30;15:1479-1486. doi: 10.2147/NDT.S198899. This study is a systematic review and meta-analysis of randomized controlled trials (RCTs) studying the effectiveness of melatonin for the amelio …
Name must be less than 100 characters Melatonin has a role in psychiatric illness and the treatment of circadian rhythm sleep disorders, insomnia, and comorbid depressive disorders.
Free PMC article